EUVIMEDEUVIMED entdecken
VergleichsstudieNetzwerk-MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence

Aditya K Gupta iD, Mary A Bamimore, Greg Williams, Mesbah Talukder iD

Journal of Cosmetic Dermatology · 2025-07 · 24 (7)

DOI: 10.1111/jocd.70320 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 30.06.2025. Verfasst von Aditya K Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mediprobe Research Inc., London, Ontario, Canada. Hauptthemen laut MEDLINE: 5-alpha Reductase Inhibitors, Alopecia, Minoxidil. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment options for male androgenetic alopecia (AGA) range from pharmacologic agents—such as minoxidil, finasteride, and dutasteride—to newer procedural and experimental therapies.

Aims

We determined the relative effect of the various dosages and administrative routes of minoxidil, finasteride and dutasteride through network meta‐analysis (NMA) of relevant outcome measures.

Methods

We conducted a systematic review to identify eligible studies. Our NMAs included studies that investigated monotherapy with minoxidil, finasteride, and dutasteride of any dosage and route on the following 5 outcomes: 24‐ and 48‐week changes in total and terminal hair density, and 24‐week change in independent observer assessment (IOA). We assessed evidence quality and performed sensitivity and node‐splitting analyses of inconsistency. Each NMA produced estimates for pairwise relative effects and surface under the cumulative ranking curve (SUCRA) values.

Results

Our search found 33 eligible studies across which 19 comparators (18 interventions and 1 control) were identified. The active comparators included minoxidil (oral, topical, sublingual), finasteride (oral, topical, mesotherapy) and dutasteride (oral, mesotherapy). The control node amalgamated placebo and vehicle arms.

Conclusions

We found dutasteride 0.5 mg/day to be the most effective option. Among FDA‐approved treatments, topical minoxidil 5% was the most effective topical monotherapy, while finasteride 1 mg/day was the most effective oral option. Dutasteride mesotherapy appears significantly less effective than oral administration (0.5 mg/day).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5-alpha Reductase InhibitorsAlopeciaMinoxidilHumansMaleAdministration, OralDutasterideFinasterideHairTreatment Outcome

Stichwörter der Autor:innen

alopeciaandrogenetic alopeciamale pattern baldness

Substanzen

5-alpha Reductase InhibitorsDutasterideFinasterideMinoxidil

Autor:innen und Institutionen

  • Mediprobe Research Inc., London, Ontario, Canada.
  • Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Farjo Hair Institute, London, UK.
  • School of Pharmacy, BRAC University, Dhaka, Bangladesh.

ORCID-Profile: Aditya K Gupta, Mesbah Talukder

Zitieren

APA

Gupta, A. K., Bamimore, M. A., Williams, G., & Talukder, M. (2025). Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence. Journal of Cosmetic Dermatology, 24(7). https://doi.org/10.1111/jocd.70320

Vancouver

Gupta AK, Bamimore MA, Williams G, Talukder M. Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence. Journal of Cosmetic Dermatology. 2025;24(7). doi:10.1111/jocd.70320

BibTeX
@article{Gupta2025,
  author = {Gupta, Aditya K and Bamimore, Mary A and Williams, Greg and Talukder, Mesbah},
  title = {Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  volume = {24},
  number = {7},
  doi = {10.1111/jocd.70320}
}
Kostenlos starten →